2026 Independent Medical Education Request for Proposals
Supports accredited medical education to improve healthcare providers' knowledge and management of MOGAD, focusing on diagnosis, testing, and new therapies to enhance neuroimmunology patient care.
Funder: Roche
Due Dates: July 24, 2026
Funding Amounts: Up to $200,000 per grant; project duration typically 12 months
Summary: Supports independent, accredited medical education to address knowledge gaps in diagnosing and managing MOGAD among healthcare providers.
Description
This grant supports independent, certified medical education initiatives aimed at improving clinical knowledge, competence, and performance among healthcare professionals in the diagnosis and management of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). The program addresses persistent gaps in distinguishing MOGAD from similar demyelinating conditions, appropriate testing protocols, interpretation of antibody titers, and the integration of new targeted therapies. The ultimate goal is to enhance evidence-based patient care in neuroimmunology.
